AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 DEC 4 - (NewsRx.com & NewsRx.net) -- A study by researchers in Switzerland suggests that passive immunization against beta-amyloid (Abeta) peptide may protect neurons from toxicity associated with Abeta.
M.H. Mohajeri and colleagues, University of Zurich, conducted a study in transgenic mice to "characterize the effects of the familial Alzheimer's disease-causing Swedish mutations of amyloid precursor protein (SwAPP) on the vulnerability of central nervous system neurons."
They caused the SwAPP-expressing mice to have epileptic seizures.
"The transgene expression did not change the seizure threshold, but consistently more neurons degenerated in brains of SwAPP mice as compared with wild-type littermates," reported the researchers. "The degenerating neurons were stained both by terminal deoxynucleotidyl transferase-mediated dUTP nick end-labeling and by Gallyas silver impregnation."
"A susceptible population of neurons accumulated intracellular Abeta and immunoreacted with antibodies against activated caspase-3," they continued. "To demonstrate that increased Abeta levels mediated the increased vulnerability, we infused antibodies against Abeta and found a significant reduction in neuronal loss that was paralleled by decreased brain levels of Abeta. Because the SwAPP mice exhibited no amyloid plaques at the age of these experiments, transgenic ...
Source: HighBeam Research, Passive immunization against beta-amyloid peptide protects CNS...